galantamine has been researched along with Psychoses in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, HC; Blais, MA; Dubois, CM; Durham, LE; Fava, M; Matthews, JD; Park, LT; Rooney, KO; Seabrook, RC; Siefert, CJ; van Nieuwenhuizen, AO; Welch, CA | 1 |
| Brown, CH; Deutsch, SI; Rosse, RB; Rosse, SM; Schooler, NR; Schwartz, BL | 1 |
| Correll, CU; Lu, RB; Luchini, C; Solmi, M; Stubbs, B; Veronese, N; Zaninotto, L | 1 |
| Adams, HA; Blanchard, JJ; Buchanan, RW; Carpenter, WT; Cohen, AS; Gold, J; Kelly, DL; McMahon, RP; Mitchell, KR; Strauss, GP | 1 |
| Boggs, DL; Buchanan, RW; Conley, RR; Dickinson, D; Kelly, DL; McMahon, RP; Weiner, E | 1 |
| Osborn, GG; Saunders, AV | 1 |
| Jayaram, MB; Kour, K; Singh, J | 1 |
| BOIADZHIEVA, M; SHCHEREVA, T; TEMKOV, I | 1 |
| Bennouna, M; Defranoux, L; Greene, VB | 1 |
| Hicks, PB; Schubert, MH; Young, KA | 1 |
3 review(s) available for galantamine and Psychoses
| Article | Year |
|---|---|
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions.
Topics: Adult; Bipolar Disorder; Case-Control Studies; Cholinesterase Inhibitors; Clinical Trials as Topic; Depression; Depressive Disorder; Donepezil; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Current treatments for patients with Alzheimer disease.
Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration | 2010 |
Acetylcholinesterase inhibitors for schizophrenia.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2012 |
5 trial(s) available for galantamine and Psychoses
| Article | Year |
|---|---|
A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy.
Topics: Affect; Amnesia, Anterograde; Cognition; Cohort Studies; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Galantamine; Humans; Inpatients; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders | 2013 |
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.
Topics: Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Synaptic Transmission; Treatment Outcome | 2013 |
The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.
Topics: Adult; Antipsychotic Agents; Facial Expression; Galantamine; Humans; Interpersonal Relations; Interview, Psychological; Middle Aged; Neuropsychological Tests; Oxytocin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Social Behavior; Speech Production Measurement; Treatment Outcome; Video Recording; Voice; Young Adult | 2017 |
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Antipsychotic Agents; Breath Tests; Carbon Monoxide; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking Cessation | 2008 |
Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Risperidone; Schizophrenia | 2006 |
2 other study(ies) available for galantamine and Psychoses
| Article | Year |
|---|---|
[Changes in the cholinesterase activity of the blood serum in some psychoses under the influence of nivaline].
Topics: Alkaloids; Cholinesterases; Electroconvulsive Therapy; Galantamine; Parasympathomimetics; Psychotherapy; Psychotic Disorders; Serum | 1960 |
Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
Topics: Adult; Antipsychotic Agents; Brain Hemorrhage, Traumatic; Cholinesterase Inhibitors; Cognition Disorders; Female; Galantamine; Humans; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology | 2005 |